Covance’s early development facility in Shanghai, China, has received GLP Certificate from the State Food and Drug Administration (SFDA) of the People’s Republic of China. The facility in Shanghai provides nonclinical safety assessment, bioanalytical, in vivo pharmacology, and DMPK services.   “Covance is now the only global CRO with SFDA GLP certification in China. Our early development facility in Shanghai offers world-class quality and expertise to companies with testing needs in China and th...